BTCC
/
BTCC Square
/
Global Cryptocurrency
/
TransMedics Stock Surges 15% on Blowout Q2 Earnings and Raised Guidance
TransMedics Stock Surges 15% on Blowout Q2 Earnings and Raised Guidance
16
3
BTCCSquare news:
TransMedics shares soared 15% after the organ transplant technology company reported second-quarter results that demolished analyst expectations. Revenue jumped 38% year-over-year, while EPS of $0.92 doubled consensus estimates. Management boosted full-year sales guidance by $20 million to $595 million at the midpoint.
The company's Organ Care System continues gaining traction, with sales growing tenfold since 2022. TransMedics demonstrated improving profitability as net margins expanded from 11% to 22% year-over-year, signaling operational efficiency gains in its logistical network. CEO Waleed Hassanein suggests the growth trajectory remains strong.
By:
Previous
Spartans.com Disrupts Online Betting with 300% Crypto Bonus, Outshining BetMGM and Bet9ja
Next
Beetz Daily Combo Update for 01 August 2025
